福元医药(601089.SH)：盐酸阿罗洛尔片获得药品注册证书

Core Viewpoint - Fuyuan Pharmaceutical (601089.SH) has received the Drug Registration Certificate for Arolol Hydrochloride Tablets (10mg) from the National Medical Products Administration, which will enhance the company's product line and market competitiveness [1] Group 1 - The drug is indicated for primary hypertension (mild to moderate), angina pectoris, tachyarrhythmia, and essential tremor [1] - The approval of the Drug Registration Certificate will further enrich the company's product offerings [1] - This development is expected to improve the company's market competitiveness [1]